Revolution Medicines, Inc. RVMD Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -76.7%-40.0pp | -58.1%-28.7pp | -60.8%-13.6pp | -46.6%-5.9pp | -36.7%-0.5pp | |
| Return on assets | -59.4%-26.8pp | -46.1%-20.1pp | -47.9%-6.6pp | -38.3%-2.3pp | -32.6%-0.2pp | |
| Return on invested capital | -89.6%-43.2pp | -72.4%-27.6pp | -69.4%-3.8pp | -59.3%-0.5pp | -46.4%+5.9pp | |
| Liquidity | ||||||
| Current ratio | 6.8×-6.7× | 7.1×-7.1× | 8.1×-6.2× | 11.8×-3.6× | 13.5×-5.0× | |
| Quick ratio | 6.8×-6.7× | 7.1×-7.1× | 8.1×-6.2× | 11.8×-3.6× | 13.5×-5.0× | |
| Cash ratio | 1.5×-0.6× | 1.3×-2.0× | 0.9×-0.9× | 2.2×-0.4× | 2.1×-1.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Interest coverage | -38.1×— | -48.8×— | -84.3×— | -1,035.2×— | —— | |
| Per Share | ||||||
| Book value per share | $7.57-31.5% | $8.58-36.5% | $8.44-10.1% | $9.89+0.9% | $11.05+5.4% | |
| Valuation | ||||||
| Market capitalization | $19.27B+193% | $15.4B+90.5% | $8.73B+15.4% | $7.46B+16.3% | $6.57B+23.8% | |
| Enterprise value | $18.99B+198% | $15.17B+97.7% | $8.67B+16.4% | $7.19B+15.5% | $6.37B+24.8% | |
| Price / book | 12.8×+9.7× | 9.4×+5.9× | 5.5×+0.6× | 4×0.0× | 3.2×+0.1× | |
| Free cash flow yield | -5.6%+3.6pp | -5.9%+1.1pp | -8.9%-1.6pp | -9.4%-1.3pp | -9.2%-0.5pp | |
| Earnings yield | -7.1%+3.5pp | -7.3%+0.1pp | -11%-3.5pp | -10.9%-2.8pp | -10.6%-1.5pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Revolution Medicines, Inc.'s ratios come from?
- Every ratio is computed from Revolution Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.